Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Certolizumab 200 Mg/2 Ml Kit [Brod] (CDM 10455106) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 3, 2026 , from http://ppman.hank.ai/transparency/procedure/10455106/by-state?code_type=CDM
“Certolizumab 200 Mg/2 Ml Kit [Brod] (CDM 10455106) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/10455106/by-state?code_type=CDM. Accessed
November 3, 2026 .
“Certolizumab 200 Mg/2 Ml Kit [Brod] (CDM 10455106) by State,” HANK Price Transparency ,
accessed November 3, 2026 ,
http://ppman.hank.ai/transparency/procedure/10455106/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
10455106 — Certolizumab 200 Mg/2 Ml Kit [Brod]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$16,142
National median
$15,973 – $16,310
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 10455106 (CDM), with interquartile range
State Median p25 p75
NE $16,142 $15,973 $16,310